Jurox, an Australian company that makes drugs and other products formulated for cats, dogs, sheep, horses and cattle, will expand to the United States with the opening of a headquarters in Kansas City, Mo. The expansion into the nation’s Animal Health Corridor, an area focused on animal-related research and manufacturing, was an easy decision, said John O’Brien, managing director for Jurox. "Kansas City is the obvious best location to launch Jurox’s U.S. operations,” O’Brien said. “The region offers a broad portfolio of animal health companies, a first-rate talent pool, and a superior transportation network that connects us to clientele around the country and globe. Kansas City’s reputation and resources in animal sciences provides advantages you can’t find elsewhere.” Jurox, a family-owned company based in Rutherford, New South Wales, Australia, produces more than 120 animal health products. They range from Popantel deworming tablets for cats or dogs to Dermaclens Cream for treating wounds in cattle, horses, dogs and cats. The move is expected to create 44 jobs–13 in Kansas City and 31 throughout the United States. A date for the opening of the Kansas City office was not announced. The decision was good news for Kansas City, said Mayor Sly James. “This announcement is further proof that our economy is growing in all the right ways and with an eye towards high-growth industries of the future,” he said. Already established in the Animal Health Corridor are companies such as Bayer Animal Health and Hill’s Pet Nutrition Inc. and educational institutions such as the Kansas State University and University of Missouri veterinary colleges.
